This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 2 from Patent US 20120302729
General Information
DRACP ID DRACP01416
Peptide Name Sequence 2 from Patent US 20120302729
Sequence LFGRAP
Sequence Length 6
UniProt ID Q57506 J7QLC0 Q5R511 O35501 Q3ZCH0 P38647 P48721 P38646 Q5ZM98 Q8Y0L9 P86233 O67549
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C31H49N9O7
Absent amino acids CDEHIKMNQSTVWY
Common amino acids AFGLPR
Mass 74915
Pl 10.55
Basic residues 1
Acidic residues 0
Hydrophobic residues 3
Net charge 1
Boman Index -427
Hydrophobicity 31.67
Aliphatic Index 81.67
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2012/0302729 A1
Patent Title Anticancer anti-mortalin peptide antibody.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: EP, US, WO, JP; Legal Status: Inactive; Application No: 201013514755; Filed:Dec 9, 2010; Published: Nov 29, 2012; Earliest Priority: Dec 10, 2009; Granted: Nov 19, 2013
Other Published ID EP2511371A1 EP2511371A4
This work is licensed under a Creative Commons Attribution 4.0 International License.